Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Vivancos

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
MYC Copy Number Detection in Clinical Samples Using a Digital DNA-Hybridization and Detection MethodZighereda Ogbah, Francesco Mattia Mancuso, Ana Vivancos
Expert Review of Molecular Diagnostics|June 11, 2025
Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guideFlorian Castet, Maria Teresa Salcedo, Paolo Nuciforo, et al.
NPJ Breast Cancer|June 19, 2024
Use of ctDNA in early breast cancer: analytical validity and clinical potentialFrançois Panet, Andri Papakonstantinou, Maria Borrell, et al.
CA: a Cancer Journal for Clinicians|November 20, 2013
New approach to cancer therapy based on a molecularly defined cancer classificationJavier Cortés, Emiliano Calvo, Ana Vivancos, et al.
Nature Reviews. Clinical Oncology|April 5, 2012
Molecular prescreening to select patient population in early clinical trialsJordi Rodón, Cristina Saura, Rodrigo Dienstmann, et al.
Nature Reviews. Clinical Oncology|May 29, 2013
Circulating tumour cells and cell-free DNA as tools for managing breast cancerLeticia De Mattos-Arruda, Javier Cortes, Libero Santarpia, et al.
Cancer Treatment Reviews|August 12, 2023
Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysisLaura Vidal, Elizabeth Pando, Laia Blanco, et al.
Frontiers in Oncology|April 29, 2026
Immune checkpoint inhibition in <i>Epstein-Barr virus</i> associated gastric cancer: a case report highlighting the role of biomarker-driven treatment selectionJesús Yaringaño, Andrea Blázquez-López, Daniel Acosta, et al.
Frontiers in Immunology|November 7, 2025
Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategiesGreta Catani, Daniel Morchón-Araujo, Oriol Mirallas, et al.
ESMO Open|April 10, 2019
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancerVictor Rodriguez-Freixinos, Fiorella Ruiz-Pace, Lorena Fariñas-Madrid, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
MYC Copy Number Detection in Clinical Samples Using a Digital DNA-Hybridization and Detection MethodZighereda Ogbah, Francesco Mattia Mancuso, Ana Vivancos
Expert Review of Molecular Diagnostics|June 11, 2025
Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guideFlorian Castet, Maria Teresa Salcedo, Paolo Nuciforo, et al.
NPJ Breast Cancer|June 19, 2024
Use of ctDNA in early breast cancer: analytical validity and clinical potentialFrançois Panet, Andri Papakonstantinou, Maria Borrell, et al.
CA: a Cancer Journal for Clinicians|November 20, 2013
New approach to cancer therapy based on a molecularly defined cancer classificationJavier Cortés, Emiliano Calvo, Ana Vivancos, et al.
Nature Reviews. Clinical Oncology|April 5, 2012
Molecular prescreening to select patient population in early clinical trialsJordi Rodón, Cristina Saura, Rodrigo Dienstmann, et al.
Nature Reviews. Clinical Oncology|May 29, 2013
Circulating tumour cells and cell-free DNA as tools for managing breast cancerLeticia De Mattos-Arruda, Javier Cortes, Libero Santarpia, et al.
Cancer Treatment Reviews|August 12, 2023
Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysisLaura Vidal, Elizabeth Pando, Laia Blanco, et al.
Frontiers in Oncology|April 29, 2026
Immune checkpoint inhibition in <i>Epstein-Barr virus</i> associated gastric cancer: a case report highlighting the role of biomarker-driven treatment selectionJesús Yaringaño, Andrea Blázquez-López, Daniel Acosta, et al.
Frontiers in Immunology|November 7, 2025
Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategiesGreta Catani, Daniel Morchón-Araujo, Oriol Mirallas, et al.
ESMO Open|April 10, 2019
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancerVictor Rodriguez-Freixinos, Fiorella Ruiz-Pace, Lorena Fariñas-Madrid, et al.
Pageof 11